Articles

This is a partial listing of articles on this site (see the Latest/Articles by Date page for all articles).

General Articles

• An Introduction to Hormone Therapy for Transfeminine People (Aly W., 2018)
• An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People (Aly W., 2019)

Special Topics

Estrogens

• Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals (Sam S., 2020)
• An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People (Sam S., 2021)
• Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People (Aly W., 2019)
• A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment (Aly W., 2019)
• Genital Application of Estradiol as a Powerful Transdermal Route for Transfeminine People (Aly W., 2019)
• Insights on Genital Application of Transdermal Estradiol Gel in Transfeminine People Scrotal Appication of Testosterone in Men (Aly W., 2019)
• An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters (Aly W., 2021)
• An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations (Aly W., 2021)
• Estrogens and Their Influences on Coagulation and Risk of Blood Clots (Aly W., 2020)
• The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance to Transfeminine People (Aly W., 2020)

Antiandrogens

• Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People (Aly W., 2019)
• Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People (Aly W., 2020)
• Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy (Aly W., 2020)
• Information on Bicalutamide (Casodex) as an Antiandrogen for Transfeminine People (Aly W., 2018)
• Bicalutamide: Frequently Asked Questions and Common Misconceptions (Aly W., 2018)
• Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies (Aly W., 2018)

Progestogens

• Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects (Aly W., 2018)
• Administration of Oral Progesterone Capsules Rectally Instead of Orally for Greatly Improved Efficacy in Transfeminine People (Aly W., 2018)
• The Influence of Progesterone and Other Progestogens on Sexual Desire and Function (Aly W., 2020)
• Progesterone and its Role in Breast Development During Female Puberty (Aly W., 2020)
• Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk (Sam S., 2020)

Other Medications

• A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy (Lain M., 2019)
• Nandrolone as an Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People (Aly W., 2020)

General Effects and Risks

• On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy (Lain M., 2020)
• On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy (Lain M., 2019)
• The Relationship Between the Endocrine System and Muscle Mass (Lain M., 2019)
• Breast Cancer Risk with Hormone Therapy in Transfeminine People (Aly W., 2020)

Miscellaneous

• Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work (Aly W., 2019)
• Commentary and Fact Check of Dr. Will Powers’s Transgender Care Presentation (Aly W., 2019)
• The Roles of Placebo and Nocebo in Medication Effects and Why Subjective Reports Are Unreliable (Aly W., 2020)
• Prenatal Diethylstilbestrol Exposure and Likelihood of Being Transgender (Aly W., 2020)

Data, Analysis, and Literature

• Clinical Guidelines with Information on Transfeminine Hormone Therapy (Aly W., 2020)
• Approximate Comparable Dosages of Estradiol by Different Routes (Aly W., 2020)
• Hormone Levels During Normal Puberty in Cisgender Girls (Aly W., 2020)
• Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018) (Aly W., 2019)
• Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer (Sam S., 2020)
• Analysis of Studies Assessing the Risk of Thromboembolism with Transfeminine Hormone Therapy (Sam S., 2020)
• Published Literature on Bicalutamide as an Antiandrogen for Transfeminine People (Aly W., 2019)
• Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy (Sam S., 2020)
• Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People (Aly W., 2019)
• Excerpts: Early Progestogen Exposure May Result in Suboptimal Breast Development (Aly W., 2019)
• Data Show That the Number of People Hormonally Transitioning has Skyrocketed in Recent Years (Aly W., 2019)